Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • Contraceptive pills...

    Contraceptive pills effective in Rheumatoid arthritis risk : BMJ

    Written by Anjali Nimesh Nimesh Published On 2017-08-19T11:00:30+05:30  |  Updated On 19 Aug 2017 11:00 AM IST
    Contraceptive pills effective in Rheumatoid arthritis risk : BMJ

    Taking the contraceptive pill, particularly for seven or more consecutive years, is linked to a lowered risk of developing rheumatoid arthritis, finds research published online in the Annals of the Rheumatic Diseases.





    But no significant link was found for breastfeeding a practice that has been associated with a protective effect after accounting for various potentially influential factors, the findings show.


    According to a new study by Karolinska Institute in Stockholm, Sweden, and published in the journal Annals of the Rheumatic Diseases it has been found that women who take the oral contraceptive pill are protected from going on to develop arthritis in later life. This has led scientists to believe hormonal and reproductive factors may contribute to the underlying cause.


    Rheumatoid arthritis an autoimmune systemic disease which mainly attacks the joints, most often the knees, hands, and wrists but it can also affect the lungs, heart, eyes, and other parts of the body. It develops between the ages of 40 and 50 and affects up to 1 percent of people worldwide.It occurs when the body’s immune system targets joints such as the wrists and ankles, causing painful swelling, and is twice as common in women as it is in men.


    Researchers believe that hormonal changes prompted by the pill may decrease the risk of suffering from the painful disease.In the study it was found that using the common contraceptive method for seven or more years was associated with a 19 per cent lower chance of developing rheumatoid arthritis.Women who had stopped using the pill still appeared to benefit from a protective effect, enjoying a 13 per cent lower risk of the condition.The data for the study was drawn from 2,809 women with the disease and compared it with the medical records of 5,312 women randomly selected from the general population. The data from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) included women aged 18 and above, living in a defined area of Sweden between 1996 and 2014.


    All participants had given blood samples, so the researchers could check for a blood marker for rheumatoid arthritis called anti-citrullinated protein antibodies (ACPAs).


    It was found that current use of contraceptive pill was linked to 15 percent reduced risk, while past use was linked to 13 percent reduced risk.The researchers suggest that there could be a "dose-response" effect: using oral contraception for more than 7 years was linked to a 19 percent ler risk of developing rheumatoid arthritis, even for women who tested negative for ACPAs.


    In this present study it was therefore concluded that women who had ever used oral contraceptives had a significantly decreased risk of developing RA .


    Although a lower risk was also found among women who had breastfed at least one child, this was not significant after potentially influential factors were accounted for.


    This is an observational study so no firm conclusions can be drawn about cause and effect, added to which the researchers were unable to glean any information about the dose or type of oral contraceptive the women used.


    But the number of participants was large, and a wide range of potentially influential factors was looked at, the researchers point out.


    For more details click on the following link : http://ard.bmj.com/content/early/2017/07/28/annrheumdis-2017-211620
    breastfeedingContraceptive pillsjournal Annals of the Rheumatic Diseasesjournal Annals Rheumatic DiseasesKarolinska Instituterheumatic diseasesrheumatoid arthritis

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok